The Gazette spoke with Andrew Chan, director of cancer epidemiology at the Mass. General Cancer Center, about the new thinking around aspirin.

A new study finds that while regular aspirin use has clear benefits in reducing colorectal cancer incidence among middle-aged adults, the benefits stop after age 70.